1.46
0.00 (0.00%)
| Previous Close | 1.46 |
| Open | 1.46 |
| Volume | 60,504 |
| Avg. Volume (3M) | 94,353 |
| Market Cap | 6,274,697 |
| Price / Book | 0.940 |
| 52 Weeks Range | |
| Earnings Date | 14 Aug 2026 |
| Diluted EPS (TTM) | -0.700 |
| Current Ratio (MRQ) | 1.93 |
| Operating Cash Flow (TTM) | -9.37 M |
| Levered Free Cash Flow (TTM) | -4.87 M |
| Return on Assets (TTM) | -106.68% |
| Return on Equity (TTM) | -285.79% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Acurx Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.0 |
| Average | 0.50 |
|
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 10.95% |
| % Held by Institutions | 18.21% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Prospect Financial Services Llc | 31 Mar 2026 | 13,785 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |